Tu, S., Zhou, X., Guo, Z., Huang, R., Yue, C., He, Y., . . . Li, Y. (2019). CD19 and CD70 Dual-Target Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Relapsed and Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma. Front Oncol.
Chicago-tyylinen lähdeviittausTu, Sanfang, et al. "CD19 and CD70 Dual-Target Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Relapsed and Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma." Front Oncol 2019.
MLA-viiteTu, Sanfang, et al. "CD19 and CD70 Dual-Target Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Relapsed and Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma." Front Oncol 2019.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.